Journal of Nephrology · 2014 · 21 citations · 18 references
MedicineNephrologyPathobiologyInflammationRenal PathologyRenal PathophysiologyChronic Kidney DiseaseInflammatory PathologyInflammatory SignalingRenal DiseaseRenal ImmunopathologyRenal InflammationEndothelial Dysfunction AssessmentInflammation In Renal InjuryInflammation-induced Endothelial DysfunctionPolycystic Kidney Disease GeneticsRenal Biomarker DiscoveryRenal Inflammatory InjuryVascular Endothelial Dysfunction
BACKGROUND/AIMS: Cardiovascular disease (CVD) is the main cause of mortality in patients with autosomal dominant polycystic kidney disease (ADPKD). Prior to hypertension early vascular changes and inflammation have been reported. We aimed to investigate long pentraxin 3 (PTX-3), which has been recently described as a biomarker of inflammation, and its relation with endothelial dysfunction in early ADPKD patients. METHODS: Twenty-five ADPKD patients without hypertension and 25 healthy controls were studied cross-sectionally. Hypertension was diagnosed with ambulatory blood pressure monitoring. Plasma concentrations of PTX-3 and proteinuria levels were obtained from each participant. Endothelial dysfunction was assessed using ischemia-induced forearm flow-mediated vasodilation (FMD). RESULTS: PTX-3 levels were higher in ADPKD patients compared to healthy controls (4.2 [1.2-10.1] vs. 1.4 [0.4-3.1] ng/ml, p < 0.001). Additionally, C-reactive protein (CRP) and proteinuria levels were higher in ADPKD patients than in healthy subjects. In the whole cohort, PTX-3 correlated negatively with FMD (r: -0.58, p < 0.001) and positively with proteinuria (r: 0.56, p < 0.001) and uric acid (r: 0.57, p < 0.001). In all subjects, FMD was independently predicted by PTX-3, but not by uric acid, CRP or proteinuria. CONCLUSION: PTX-3 may be a better biomarker of inflammation than CRP to predict endothelial dysfunction in normotensive ADPKD patients with well-preserved kidney function. Hence, inflammation which is demonstrated by PTX-3 may potentially be used to predict future CVD in this population.
18
David S. Celermajer, Keld E. Sørensen, Michael Ryalls et al. · Journal of the American College of Cardiology · 1993 · 253 citations
Inducible expression of PTX3, a new member of the pentraxin family, in human mononuclear phagocytes
VV Alles, Barbara Bottazzi, Giuseppe Peri et al. · Blood · 1994 · 252 citations · Full text